Evaluation of thrombogenic effects of drugs.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D000991:Antithrombins / Q000378:metabolism; D001772:Blood Cell Count; D001779:Blood Coagulation Factors / Q000378:metabolism; D001792:Blood Platelets / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D000242:Cyclic AMP / Q000378:metabolism; D003864:Depression, Chemical; D004285:Dogs; D004727:Endothelium / Q000187:drug effects; D005342:Fibrinolysis / Q000187:drug effects; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D007509:Irritants / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D013268:Stimulation, Chemical; D013499:Surface Properties; D013925:Thromboplastin / Q000378:metabolism; D013927:Thrombosis / Q000139:chemically induced*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000970:Antineoplastic Agents; D000991:Antithrombins; D001779:Blood Coagulation Factors; D007509:Irritants; D014662:Vasoconstrictor Agents; D013925:Thromboplastin; D000242:Cyclic AMP